9 METERS BIOPHARMA, INC. Quarterly Liabilities and Equity in USD from Q4 2015 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
9 Meters Biopharma, Inc. quarterly Liabilities and Equity history and growth rate from Q4 2015 to Q1 2023.
  • 9 Meters Biopharma, Inc. Liabilities and Equity for the quarter ending March 31, 2023 was $9.31M, a 76.3% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $9.31M -$30M -76.3% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $33.1M -$17M -33.9% Dec 31, 2022 10-Q 2023-05-15
Q3 2022 $42.1M -$14.5M -25.7% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $31.5M -$34.5M -52.3% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $39.3M -$944K -2.35% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $50.2M +$11M +28.1% Dec 31, 2021 10-K 2023-03-28
Q3 2021 $56.7M +$42.8M +307% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $66M +$51.3M +349% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $40.2M +$36.9M +1124% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $39.2M +$33.9M +639% Dec 31, 2020 10-K 2022-03-23
Q3 2020 $13.9M +$4.1M +41.8% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $14.7M +$42.5K +0.29% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $3.29M -$9.3M -73.9% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $5.3M -$1.16M -17.9% Dec 31, 2019 10-K 2021-03-22
Q3 2019 $9.81M +$1.13M +13% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $14.6M +$3.68M +33.6% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $12.6M -$695K -5.23% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $6.45M +$5.66M +708% Dec 31, 2018 10-K 2020-03-20
Q3 2018 $8.68M +$5.29M +156% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 $11M +$7.41M +209% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 $13.3M +$8.86M +200% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 $798K -$5.67M -87.6% Dec 31, 2017 10-K 2019-03-18
Q3 2017 $3.39M -$5.2M -60.6% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $3.55M -$2.37M -40.1% Jun 30, 2017 10-Q 2017-08-21
Q1 2017 $4.42M Mar 31, 2017 10-Q 2017-05-19
Q4 2016 $6.46M +$1.75M +37% Dec 31, 2016 10-K 2018-03-14
Q3 2016 $8.59M Sep 30, 2016 10-Q 2016-11-16
Q2 2016 $5.92M Jun 30, 2016 10-Q 2016-08-15
Q4 2015 $4.72M Dec 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.